These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15810882)

  • 21. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism.
    Schümann J; Facciotti F; Panza L; Michieletti M; Compostella F; Collmann A; Mori L; De Libero G
    Eur J Immunol; 2007 Jun; 37(6):1431-41. PubMed ID: 17492806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection.
    Lin Y; Roberts TJ; Spence PM; Brutkiewicz RR
    J Leukoc Biol; 2005 Feb; 77(2):151-8. PubMed ID: 15548574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
    Peralbo E; Alonso C; Solana R
    Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo.
    Chung Y; Kim BS; Kim YJ; Ko HJ; Ko SY; Kim DH; Kang CY
    Cancer Res; 2006 Jul; 66(13):6843-50. PubMed ID: 16818662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
    Miyake S; Yamamura T
    Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
    Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
    Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung.
    Nieuwenhuis EE; Matsumoto T; Exley M; Schleipman RA; Glickman J; Bailey DT; Corazza N; Colgan SP; Onderdonk AB; Blumberg RS
    Nat Med; 2002 Jun; 8(6):588-93. PubMed ID: 12042809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid rafts are required for efficient signal transduction by CD1d.
    Park YK; Lee JW; Ko YG; Hong S; Park SH
    Biochem Biophys Res Commun; 2005 Feb; 327(4):1143-54. PubMed ID: 15652515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells.
    Kang SJ; Cresswell P
    Nat Immunol; 2004 Feb; 5(2):175-81. PubMed ID: 14716312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous or oral administration of rhIL-11 modulated the contact hypersensitivity response.
    Peterson RL; Wang LL; Albert L; Dorner AJ
    Cytokine; 2000 Dec; 12(12):1769-77. PubMed ID: 11097746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes".
    Arora P; Kharkwal SS; Ng TW; Kunnath-Velayudhan S; Saini NK; Johndrow CT; Chang YT; Besra GS; Porcelli SA
    Chem Phys Lipids; 2016 Jan; 194():49-57. PubMed ID: 26496152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD1d knockout mice exhibit aggravated contact hypersensitivity responses due to reduced interleukin-10 production predominantly by regulatory B cells.
    Fjelbye J; Antvorskov JC; Buschard K; Issazadeh-Navikas S; Engkilde K
    Exp Dermatol; 2015 Nov; 24(11):853-6. PubMed ID: 26121177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction is connected with their suppressive effect on NKT and CD8(+) T cells but not on TCR delta T cells.
    Curzytek K; Kubera M; Majewska-Szczepanik M; Szczepanik M; Ptak W; Duda W; Leśkiewicz M; Basta-Kaim A; Budziszewska B; Regulska M; Korzeniak B; Głombik K; Maes M; Lasoń W
    Int Immunopharmacol; 2015 Oct; 28(2):1091-6. PubMed ID: 26315493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invariant NKT cells as initiators, licensors, and facilitators of the adaptive immune response.
    Stein-Streilein J
    J Exp Med; 2003 Dec; 198(12):1779-83. PubMed ID: 14676293
    [No Abstract]   [Full Text] [Related]  

  • 35. Computational structure activity relationship studies on the CD1d/glycolipid/TCR complex using AMBER and AUTODOCK.
    Nadas J; Li C; Wang PG
    J Chem Inf Model; 2009 Feb; 49(2):410-23. PubMed ID: 19434842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cd1d-restricted cellular lysis by peripheral blood lymphocytes: relevance to the inflammatory bowel diseases.
    Page MJ; Poritz LS; Tilberg AF; Zhang WJ; Chorney MJ; Koltun WA
    J Surg Res; 2000 Aug; 92(2):214-21. PubMed ID: 10896824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells.
    Spada FM; Koezuka Y; Porcelli SA
    J Exp Med; 1998 Oct; 188(8):1529-34. PubMed ID: 9782130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly conserved antigen-presenting function of CD1d molecules.
    Brossay L; Kronenberg M
    Immunogenetics; 1999 Nov; 50(3-4):146-51. PubMed ID: 10602876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A closer look at CD1d molecules: new horizons in studying NKT cells.
    Stronge VS; Salio M; Jones EY; Cerundolo V
    Trends Immunol; 2007 Oct; 28(10):455-62. PubMed ID: 17825624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of CD1D-/- mice to elicit hypersensitive granulomas to mycobacterial cord factor trehalose 6,6'-dimycolate.
    Guidry TV; Olsen M; Kil KS; Hunter RL; Geng YJ; Actor JK
    J Interferon Cytokine Res; 2004 Jun; 24(6):362-71. PubMed ID: 15212710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.